Skip to main content
Godfrey Pearlson, MD, Psychiatry, Hartford, CT

Godfrey D Pearlson MD


Professor, Psychiatry, Yale University School of Medicine. Founding Director of the Olin Neuropsychiatry Research Center.

Join to View Full Profile
  • 80 Seymour StreetHartford, CT 06106

  • Phone+1 860-972-0001

Dr. Pearlson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Psychiatry, 1976 - 1979
  • University of Newcastle Upon Tyne Faculty of Medicine
    University of Newcastle Upon Tyne Faculty of MedicineClass of 1974

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 2002 - 2026
  • MD State Medical License
    MD State Medical License 1978 - 2015
  • Psychiatry
    American Board of Psychiatry and Neurology Psychiatry

Clinical Trials

Publications & Presentations

PubMed

Authored Content

  • S188. Emotional Processing in Bipolar Disorder with and Without Psychosis: Findings from the Psychosis and Affective Research Domains and Intermediate Phenotypes ConsortiumApril 2018
  • S188. Emotional Processing in Bipolar Disorder with and Without Psychosis: Findings from the Psychosis and Affective Research Domains and Intermediate Phenotypes ConsortiumApril 2018

Press Mentions

  • Yale Researchers Awarded $20.6M Grant for Wide-Ranging Study of Mental Illness
    Yale Researchers Awarded $20.6M Grant for Wide-Ranging Study of Mental IllnessAugust 29th, 2024
  • Cannabis Sales Are Now Legal in Connecticut. How Does the Drug Work?
    Cannabis Sales Are Now Legal in Connecticut. How Does the Drug Work?February 12th, 2023
  • IOL Receives $1.5M National Grant to Study Therapeutic Approaches to Psychotic Disorders
    IOL Receives $1.5M National Grant to Study Therapeutic Approaches to Psychotic DisordersAugust 31st, 2022
  • Join now to see all

Grant Support

  • IMPACT-MH: Clinical and behavioral fingerprints of psychopathologyYALE UNIVERSITY2024–2029
  • IMPACT-MH: Clinical and behavioral fingerprints of psychopathologyYALE UNIVERSITY2024–2029
  • IMPACT-MH: Clinical and behavioral fingerprints of psychopathologyYALE UNIVERSITY2024–2029
  • 3/5 Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services (BICEPS)YALE UNIVERSITY2022–2027
  • 3/5 Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services (BICEPS)YALE UNIVERSITY2022–2027
  • 3/5 Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services (BICEPS)YALE UNIVERSITY2022–2027
  • 3/5 Selective Antipsychotic Response to Clozapine in B-SNIP Biotype-1 (CLOZAPINE)YALE UNIVERSITY2021–2026
  • Neuroimaging predictors of bariatric surgical outcomesHARTFORD HOSPITAL2018–2025

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: